Impact of ICU on the Quality of Life in Cancer Patients
QdV-ONCOREA
2 other identifiers
observational
60
1 country
1
Brief Summary
This is an observational, prospective, monocentric, case-control study. Investigators aim to compare the quality of life and oncological treatment strategy in cancer patients admitted or not in ICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2020
CompletedStudy Start
First participant enrolled
February 24, 2020
CompletedFirst Posted
Study publicly available on registry
March 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2021
CompletedSeptember 1, 2021
August 1, 2021
1.4 years
February 20, 2020
August 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
quality of life questionary 36-item short form survey instrument (36-SF)
score of 0 (poor quality of life) to 100 (very good quality of life)
3 months
Secondary Outcomes (6)
intensity of antitumoral treatment compared to standard treatment
3 months
quality of life questionary 36-item short form survey instrument (36-SF)
6 months
intensity of antitumoral treatment compared to standard treatment
6 months
ECOG - Performance status
3 months and 6 months
Activities of Daily Living
6 months
- +1 more secondary outcomes
Study Arms (2)
Cases
* \> 18 years old * Non-opposition of the patient or relatives * Lung, head and neck or colorectal cancer * Non scheduled ICU admission * At least 24 hours of ICU stay * Alive at ICU discharge * Able to answer by phone to quality of life questionary
Controls
Cancer patients not admitted in ICU, matched with the cases according to * the type of primary cancer * the presence or absence of oncogenic addiction * the setting of anticancer treatment (curative/palliative) * the line of anticancer treatment (none/L1/L2-L3/\>L3).
Interventions
Quality of life questionary: 36-Item Short Form Survey Instrument (36-SF) at 3 and 6 months from inclusion By phone
Eligibility Criteria
Lung, head and neck or colorectal cancer admitted in ICU (cases) or not (controls)
You may qualify if:
- \> 18 ans
- Non-opposition of the patient or relatives
- Lung, head and neck or colorectal cancer
- Non scheduled ICU admission
- At least 24 hours of ICU stay
- Alive at ICU discharge
- Able to answer by phone to quality of life questionary
You may not qualify if:
- Unable to answer by phone to quality of life questionary
- Patient participating in another clinical study that could interfere with the results of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Grenoble Alpes
Grenoble, 38043, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2020
First Posted
March 17, 2020
Study Start
February 24, 2020
Primary Completion
July 13, 2021
Study Completion
July 13, 2021
Last Updated
September 1, 2021
Record last verified: 2021-08